<DOC>
	<DOC>NCT01205009</DOC>
	<brief_summary>In an era of delayed fertility plans, there is increasing need for fertility treatment in older women with poor response. Human chorionic gonadotropin (hCG) supplementation prior to treatment, as a thecal stimulant, may improve folliculogenesis and ovarian response.</brief_summary>
	<brief_title>Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders</brief_title>
	<detailed_description />
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>women &gt;39 years on IVF treatment polycystic ovary syndrome Any allergy to injection of human chorionic gonadotropin before</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>in-vitro fertilization</keyword>
	<keyword>poor responders</keyword>
	<keyword>human chorionic gonadotropin</keyword>
	<keyword>Fertility Agents, Female</keyword>
</DOC>